--- title: "Lejla Delic, M.D. | Sutter Health" url: "https://www.sutterhealth.org/research/investigators/lejla-delic-md-1049681192" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Investigators](https://www.sutterhealth.org/research/investigators) / 4. Lejla Delic, M.D. ![Lejla Delic, M.D.](https://dyn.mktgcdn.com/p/MhbTJyRjrzQWGQjgKkMHD2JQrP_jl55thR0iad1Vw34/fit=crop,gravity=auto,dpr=2,width=240,height=240) # Lejla Delic, M.D. Investigator [View profile](https://www.sutterhealth.org/find-provider/dr-lejla-delic-1046238375) Lejla Delic, MD, is a board-certified gynecologic oncologist with extensive experience in the diagnosis and treatment of complex gynecologic cancers. She currently practices with Palo Alto Medical Foundation Group, providing comprehensive, patient-centered oncologic care. Dr. Delic completed her gynecologic oncology fellowship at UCLA/Cedars-Sinai Medical Center and her residency in obstetrics and gynecology at Northwestern Memorial Hospital in Chicago. She has held clinical roles across leading institutions, managing a high volume of technically challenging cases and delivering advanced surgical and medical treatments. Her clinical interests include ovarian, cervical, and endometrial cancers, and she has contributed to research on chemotherapy, radiation therapy outcomes, and immunologic responses in gynecologic malignancies. Dr. Delic is an active member of the Society of Gynecologic Oncology and the American College of Obstetricians and Gynecologists and is fluent in Bosnian, Serbian, and Croatian. ## Clinical trials - Clinical trial ### [Adjuvant Endometrial Cancer GCT1184-03](https://www.sutterhealth.org/research/clinical-trials/adjuvant-endometrial-cancer-gct1184-03-2064306931) A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator's Choice (IC) in Patients With Endometrial Cancer After Platinum-Based Chemotherapy and PD(L)-1 Therapy **Status:** Open to Enrollment - Clinical trial ### [Neoadjuvant Gynecological Cancers CORT125134-557 BELLA](https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-gynecological-cancers-cort125134-557-bella-2072220354) An Open-label, Global, Multi-Arm Study to Evaluate the Efficacy and Safety of Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers (BELLA) **Status:** Open to Enrollment ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/investigators/lejla-delic-md-1049681192#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Investigators","item":"https://www.sutterhealth.org/research/investigators"},{"@type":"ListItem","position":4,"name":"Lejla Delic, M.D."}]} ``` ```json {"@context":"https://schema.org","@type":"ProfilePage","@id":"https://www.sutterhealth.org/research/investigators/lejla-delic-md-1049681192#profilepage","url":"https://www.sutterhealth.org/research/investigators/lejla-delic-md-1049681192","name":"Lejla Delic, M.D.","dateModified":"2026-06-05","breadcrumb":{"@id":"https://www.sutterhealth.org/research/investigators/lejla-delic-md-1049681192#breadcrumblist"},"primaryImageOfPage":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/MhbTJyRjrzQWGQjgKkMHD2JQrP_jl55thR0iad1Vw34/400x400.webp","width":400,"height":400},"mainEntity":{"@id":"https://www.sutterhealth.org/research/investigators/lejla-delic-md-1049681192"}} ``` ```json {"@context":"https://schema.org","@type":"Person","@id":"https://www.sutterhealth.org/research/investigators/lejla-delic-md-1049681192","name":"Lejla Delic, M.D.","givenName":"Lejla","familyName":"Delic","honorificSuffix":"M.D.","description":"Lejla Delic, MD, is a board-certified gynecologic oncologist with extensive experience in the diagnosis and treatment of complex gynecologic cancers. She currently practices with Palo Alto Medical Foundation Group, providing comprehensive, patient-centered oncologic care. Dr. Delic completed her gynecologic oncology fellowship at UCLA/Cedars-Sinai Medical Center and her residency in obstetrics and gynecology at Northwestern Memorial Hospital in Chicago. She has held clinical roles across leading institutions, managing a high volume of technically challenging cases and delivering advanced surgical and medical treatments. Her clinical interests include ovarian, cervical, and endometrial cancers, and she has contributed to research on chemotherapy, radiation therapy outcomes, and immunologic responses in gynecologic malignancies. Dr. Delic is an active member of the Society of Gynecologic Oncology and the American College of Obstetricians and Gynecologists and is fluent in Bosnian, Serbian, and Croatian.","image":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/MhbTJyRjrzQWGQjgKkMHD2JQrP_jl55thR0iad1Vw34/400x400.webp","representativeOfPage":true},"affiliation":{"@id":"https://www.sutterhealth.org/#medicalorganization"},"mainEntityOfPage":{"@id":"https://www.sutterhealth.org/research/investigators/lejla-delic-md-1049681192#profilepage"},"sameAs":"https://www.sutterhealth.org/find-provider/dr-lejla-delic-1046238375"} ```